CHS-0214

· Coherus Oncology, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CHS-0214, covering 2019-05-13 to 2019-06-26. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA) [Phase 3]